Clinical Trials Browser

Observational × Uterine Neoplasms × 90 days × Clear all

Uterine Neoplasms

NCT03762733 2026-04-08

Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies

Enrolling by invitation

500 enrolled

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT06447064 2026-03-25

(CLOCS-2)

Recruiting

2,900 enrolled

GastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT03987555 2026-03-18

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Suspended

22 enrolled

BreastGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms

NCT05977621 2026-03-06

(TRUS)

Recruiting

17 enrolled

Gynecologic

Uterine Neoplasms

NCT07393633 2026-02-10

Assessing Whole-body Metabolism in Gynecologic Cancers in Response to a Single Chemotherapy Cycle and/ or Immunotherapy

Completed

43 enrolled

Gynecologic

Ovarian Neoplasms, Uterine Neoplasms

NCT07382505 2026-02-02

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

Not yet recruiting

600 enrolled

Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Neoplasm, Residual

Clinical Trials

PROACTION:

Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies

(CLOCS-2)

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

(TRUS)

Assessing Whole-body Metabolism in Gynecologic Cancers in Response to a Single Chemotherapy Cycle and/ or Immunotherapy

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer